Late onset globoid cell leukodystrophy

Verdru, P
October 1992
Journal of Neurology, Neurosurgery & Psychiatry;Oct1992, Vol. 55 Issue 10, p980
Academic Journal
No abstract available.


Related Articles

  • Doença de Krabbe: a importância do diagnóstico precoce para seu prognóstico. Sano, Tatiana Suemi // Einstein (16794508);abr-jun2012, Vol. 10 Issue 2, p233 

    Krabbe disease (globoid cell leukodystrophy) is an inherited recessive autosomal leukodystrophy caused by deficiency of the enzyme galactocerebrosidase. The lack of this enzyme leads to the build-up of galactolipids that will promote the death of oligodendrocytes and the demyelination of the...

  • Deletion of exons 11—17 and novel mutations of the galactocerebrosidase gene in adult- and early-onset patients with Krabbe disease. Selleri, S.; Torchiana, E.; Pareyson, D.; Lulli, L.; Bertagnolio, B; Savoiardo, M.; Farina, L.; Carrara, F.; Filocamo, M.; Gatti, R.; Sghirlanzoni, A.; Uziel, G.; Finocchiaro, G. // Journal of Neurology;Nov2000, Vol. 247 Issue 11, p875 

    Presents a letter to the editor providing information about globoid cell leukodystrophy.

  • Globoid Cell Leukodystrophy (Krabbe's Disease): Update. Suzuki, Kunihiko // Journal of Child Neurology;Sep2003, Vol. 18 Issue 9, p595 

    The classic globoid cell leukodystrophy (Krabbe's disease) is caused by genetic defects in a lysosomal enzyme, galactosylceramidase. It is one of the two classic genetic; leukodystrophies, together with metachromatic leukodystrophy. The mode of inheritance is autosomal recessive. Typically, the...

  • Krabbe's disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1275 

    A definition of the medical term "Krabbe's disease," which refers to globoid cell leukodystrophy caused by the accumulation of galactocerebroside in the tissues, is presented.

  • Globoid Cell Leukodystrophy in Cairn and West Highland White Terriers. Wenger, D.A.; Victoria, T. // Journal of Heredity;Jan/Feb99, Vol. 90 Issue 1, p138 

    Presents information on a study of Krabbe disease or globoid cell leukodystrophy (GLD) in dogs. Information on genotyping of individual dogs; Use of magnetic resonance imaging; Results and discussion.

  • 972. HSC-Based Ex Vivo Gene Therapy Prolongs Survival and Improves the Phenotype of Globoid Cell Leukodystrophy Mice Biffi, Alessandra; Visigalli, Ilaria; Politi, Letterio S.; Quattrini, Angelo; Del Carro, Ubaldo; Wenger, David; Bordignon, Claudio; Naldini, Luigi // Molecular Therapy;Jun2005, Vol. 11, p375 

    An abstract of the article "HSC-Based Ex Vivo Gene Therapy Prolongs Survival and Improves the Phenotype of Globoid Cell Leukodystrophy Mice," by Alessandra Biffi and colleagues is presented.

  • CITATIONS AND CLINICIANS' NOTES: PATHOPHYSIOLOGY/PATHOLOGY.  // Current Medical Literature: Lysosomal Storage Disease;2005, Vol. 5 Issue 2, p39 

    Discusses the histopathologic correlates of radial stripes of magnetic resonance imaging in lysosomal storage disorders. Presence of stripes in patients with globoid cell leukodystrophy and metachromatic leukodystrophy (MLD); Citations of relative sparing of myelin in the peri-venular regions of...

  • leukodystrophy.  // Taber's Cyclopedic Medical Dictionary;2005, p1232 

    A definition of the medical term "leukodystrophy" is presented. It refers to any disease such as globoid cell leukodystrophy, whose hallmarks are metabolic defects in the formation of myelin. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co. The...

  • Gene Therapy: MicroRNAs provide powerful postponement. Burgess, Darren J. // Nature Reviews Genetics;Jan2011, Vol. 12 Issue 1, p4 

    The article discusses research being done on genetic therapy for globoid cell leukodystrophy (GLD) using MicroRNA. It references the study "Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy," by B. Gentner and colleagues in the 2010...

  • Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Peters, C; Steward, C G // Bone Marrow Transplantation;2/15/2003, Vol. 31 Issue 4, p229 

    For the past two decades, hematopoietic cell transplantation (HCT) has been used as effective therapy for selected inherited metabolic diseases (IMD) including Hurler (MPS IH) and Maroteaux-Lamy (MPS VI) syndromes, childhood-onset cerebral X-linked adrenoleukodystrophy (X-ALD), globoid-cell...


Read the Article


Sign out of this library

Other Topics